| Strategy frequency per group | |||||
| Treatment | Group | LB | HB | LA | HA |
| CI-quality | 1 | 0% | 0% | 97% | 3% |
| CI-quality | 2 | 0% | 3% | 83% | 13% |
| CI-quality | 3 | 0% | 0% | 87% | 13% |
| CI-quality | 4 | 0% | 97% | 0% | 3% |
| CI-quality | 5 | 0% | 0% | 83% | 17% |
| CI-quality | 6 | 0% | 3% | 97% | 0% |
| CI-quality | 7 | 7% | 3% | 63% | 27% |
| CI-quality | 8 | 0% | 3% | 3% | 93% |
| CI-quality | 9 | 3% | 0% | 60% | 37% |
| Treatment | Group | LB | HB | LA | HA |
| CI-price | 1 | 20% | 77% | 3% | 0% |
| CI-price | 2 | 3% | 3% | 90% | 3% |
| CI-price | 3 | 27% | 0% | 60% | 13% |
| CI-price | 4 | 3% | 3% | 80% | 13% |
| CI-price | 5 | 13% | 13% | 57% | 17% |
| CI-price | 6 | 27% | 17% | 53% | 3% |
| CI-price | 7 | 3% | 0% | 97% | 0% |
| CI-price | 8 | 87% | 7% | 7% | 0% |
| Treatment | Group | LB | HB | LA | HA |
| II | 1 | 20% | 7% | 50% | 23% |
| II | 2 | 20% | 0% | 57% | 23% |
| II | 3 | 10% | 27% | 17% | 47% |
| II | 4 | 7% | 0% | 37% | 57% |
| II | 5 | 10% | 3% | 0% | 87% |
| II | 6 | 17% | 7% | 37% | 40% |